A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer

B. Nervi, A. Denes, Matthew J. Ellis

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer'. Together they form a unique fingerprint.